Occurrence of Cytosolic Protein and Phosphoprotein Changes in Human Colon Tumor Cells with the Development of Resistance to Mitomycin C

Charles W. Taylor, Michael G. Brattain, Lynn C. Yeoman

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The cytosolic proteins and phosphoproteins of a mitomycin C-sensitive cell line were examined as progressively greater doses of mitomycin C were administered over a period of 44 weeks. Resistance of the human colon carcinoma cell line increased from a 50% inhibitory concentration of 1 to 6 over this time period. Changes in cytosolic protein patterns included increases in the amounts of three proteins with molecular weight x 10 apparent isoelectric point (Mr/pl) values of 56/6.2, 37/7.3, and 27/6.1. Analysis of in vitro 32P-labeled phosphoprotein patterns revealed reductions in the amounts of four proteins with Mr/pl values of 42/6.3,40/6.7, 31/6.3, and 25/6.1. One increase was detected in a phosphoprotein with a Mr/pl value of 33/6.1. These changes in cytosolic components paralleled the development of resistance to mitomycin C and may reflect changes in the clonal composition of the cell line as it becomes progressively more resistant to mitomycin C or changes in critical proteins or enzymes involved in the activation or biotransformation of the drug.

Original languageEnglish (US)
Pages (from-to)4422-4427
Number of pages6
JournalCancer Research
Volume45
Issue number9
StatePublished - Sep 1985

Fingerprint

Phosphoproteins
Mitomycin
Colon
Neoplasms
Proteins
Cell Line
Isoelectric Point
Biotransformation
Inhibitory Concentration 50
Molecular Weight
Carcinoma
Enzymes
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Occurrence of Cytosolic Protein and Phosphoprotein Changes in Human Colon Tumor Cells with the Development of Resistance to Mitomycin C. / Taylor, Charles W.; Brattain, Michael G.; Yeoman, Lynn C.

In: Cancer Research, Vol. 45, No. 9, 09.1985, p. 4422-4427.

Research output: Contribution to journalArticle

Taylor, Charles W. ; Brattain, Michael G. ; Yeoman, Lynn C. / Occurrence of Cytosolic Protein and Phosphoprotein Changes in Human Colon Tumor Cells with the Development of Resistance to Mitomycin C. In: Cancer Research. 1985 ; Vol. 45, No. 9. pp. 4422-4427.
@article{29e1a3791ff048c89d0c6c2f2c90aa32,
title = "Occurrence of Cytosolic Protein and Phosphoprotein Changes in Human Colon Tumor Cells with the Development of Resistance to Mitomycin C",
abstract = "The cytosolic proteins and phosphoproteins of a mitomycin C-sensitive cell line were examined as progressively greater doses of mitomycin C were administered over a period of 44 weeks. Resistance of the human colon carcinoma cell line increased from a 50{\%} inhibitory concentration of 1 to 6 over this time period. Changes in cytosolic protein patterns included increases in the amounts of three proteins with molecular weight x 10 apparent isoelectric point (Mr/pl) values of 56/6.2, 37/7.3, and 27/6.1. Analysis of in vitro 32P-labeled phosphoprotein patterns revealed reductions in the amounts of four proteins with Mr/pl values of 42/6.3,40/6.7, 31/6.3, and 25/6.1. One increase was detected in a phosphoprotein with a Mr/pl value of 33/6.1. These changes in cytosolic components paralleled the development of resistance to mitomycin C and may reflect changes in the clonal composition of the cell line as it becomes progressively more resistant to mitomycin C or changes in critical proteins or enzymes involved in the activation or biotransformation of the drug.",
author = "Taylor, {Charles W.} and Brattain, {Michael G.} and Yeoman, {Lynn C.}",
year = "1985",
month = "9",
language = "English (US)",
volume = "45",
pages = "4422--4427",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Occurrence of Cytosolic Protein and Phosphoprotein Changes in Human Colon Tumor Cells with the Development of Resistance to Mitomycin C

AU - Taylor, Charles W.

AU - Brattain, Michael G.

AU - Yeoman, Lynn C.

PY - 1985/9

Y1 - 1985/9

N2 - The cytosolic proteins and phosphoproteins of a mitomycin C-sensitive cell line were examined as progressively greater doses of mitomycin C were administered over a period of 44 weeks. Resistance of the human colon carcinoma cell line increased from a 50% inhibitory concentration of 1 to 6 over this time period. Changes in cytosolic protein patterns included increases in the amounts of three proteins with molecular weight x 10 apparent isoelectric point (Mr/pl) values of 56/6.2, 37/7.3, and 27/6.1. Analysis of in vitro 32P-labeled phosphoprotein patterns revealed reductions in the amounts of four proteins with Mr/pl values of 42/6.3,40/6.7, 31/6.3, and 25/6.1. One increase was detected in a phosphoprotein with a Mr/pl value of 33/6.1. These changes in cytosolic components paralleled the development of resistance to mitomycin C and may reflect changes in the clonal composition of the cell line as it becomes progressively more resistant to mitomycin C or changes in critical proteins or enzymes involved in the activation or biotransformation of the drug.

AB - The cytosolic proteins and phosphoproteins of a mitomycin C-sensitive cell line were examined as progressively greater doses of mitomycin C were administered over a period of 44 weeks. Resistance of the human colon carcinoma cell line increased from a 50% inhibitory concentration of 1 to 6 over this time period. Changes in cytosolic protein patterns included increases in the amounts of three proteins with molecular weight x 10 apparent isoelectric point (Mr/pl) values of 56/6.2, 37/7.3, and 27/6.1. Analysis of in vitro 32P-labeled phosphoprotein patterns revealed reductions in the amounts of four proteins with Mr/pl values of 42/6.3,40/6.7, 31/6.3, and 25/6.1. One increase was detected in a phosphoprotein with a Mr/pl value of 33/6.1. These changes in cytosolic components paralleled the development of resistance to mitomycin C and may reflect changes in the clonal composition of the cell line as it becomes progressively more resistant to mitomycin C or changes in critical proteins or enzymes involved in the activation or biotransformation of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0022410423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022410423&partnerID=8YFLogxK

M3 - Article

C2 - 3928156

AN - SCOPUS:0022410423

VL - 45

SP - 4422

EP - 4427

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 9

ER -